Cosmo First Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 13, 2025, 2:59 am

Quick Insight

Cosmo First Ltd, a Packaging & Containers player, currently trades at a price of 1,078 with a market capitalization of 2,829 Cr., boasting a P/E ratio of 21.7. The company's Return on Equity (ROE) stands at 9.26%, while Return on Capital Employed (ROCE) registers at 9.77%. Operating Profit Margin (OPM) is at 9%, with a Net Profit of 133 Cr. Promoters hold a significant 40.98% stake, while FIIs and DIIs have 3.99% and 0.69% holdings, respectively. With a healthy P/BV of 1.10x and Interest Coverage Ratio (ICR) of 3.64x, Cosmo First Ltd appears to be in a stable financial position despite its 1,438 Cr. in borrowings. The absence of information on Cash Conversion Cycle (CCC) warrants further investigation, but overall, the company's strong fundamentals and reasonable valuation suggest potential for growth in the Packaging & Containers sector.

Competitors of Cosmo First Ltd

All Competitor Stocks of Cosmo First Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:25 am

Below is a detailed analysis of the quarterly data for Cosmo First Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 746.00 Cr.. The value appears strong and on an upward trend. It has increased from 701.00 Cr. (Dec 2024) to 746.00 Cr., marking an increase of 45.00 Cr..
• For Expenses, as of Mar 2025, the value is 676.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 638.00 Cr. (Dec 2024) to 676.00 Cr., marking an increase of 38.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 63.00 Cr. (Dec 2024) to 70.00 Cr., marking an increase of 7.00 Cr..
• For OPM %, as of Mar 2025, the value is 9.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 9.00%.
• For Other Income, as of Mar 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Dec 2024) to 15.00 Cr., marking a decrease of 8.00 Cr..
• For Interest, as of Mar 2025, the value is 27.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Dec 2024) to 27.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Mar 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Dec 2024) to 26.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Dec 2024) to 33.00 Cr., marking a decrease of 3.00 Cr..
• For Tax %, as of Mar 2025, the value is 17.00%. The value appears to be improving (decreasing) as expected. It has decreased from 19.00% (Dec 2024) to 17.00%, marking a decrease of 2.00%.
• For Net Profit, as of Mar 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Dec 2024) to 27.00 Cr., marking a decrease of 3.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 10.32. The value appears to be declining and may need further review. It has decreased from 11.26 (Dec 2024) to 10.32, marking a decrease of 0.94.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:02 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:31 pm

Below is a detailed analysis of the balance sheet data for Cosmo First Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 26.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,440.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,321.00 Cr. (Mar 2024) to 1,440.00 Cr., marking an increase of 119.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,438.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,048.00 Cr. (Mar 2024) to 1,438.00 Cr., marking an increase of 390.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,199.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,117.00 Cr. (Mar 2024) to 1,199.00 Cr., marking an increase of 82.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 4,103.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,512.00 Cr. (Mar 2024) to 4,103.00 Cr., marking an increase of 591.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,820.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,589.00 Cr. (Mar 2024) to 1,820.00 Cr., marking an increase of 231.00 Cr..
• For CWIP, as of Mar 2025, the value is 589.00 Cr.. The value appears strong and on an upward trend. It has increased from 357.00 Cr. (Mar 2024) to 589.00 Cr., marking an increase of 232.00 Cr..
• For Investments, as of Mar 2025, the value is 390.00 Cr.. The value appears to be declining and may need further review. It has decreased from 406.00 Cr. (Mar 2024) to 390.00 Cr., marking a decrease of 16.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,305.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,160.00 Cr. (Mar 2024) to 1,305.00 Cr., marking an increase of 145.00 Cr..
• For Total Assets, as of Mar 2025, the value is 4,103.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,512.00 Cr. (Mar 2024) to 4,103.00 Cr., marking an increase of 591.00 Cr..

Notably, the Reserves (1,440.00 Cr.) exceed the Borrowings (1,438.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Cosmo First Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 51.46. This value is within the healthy range. It has increased from 23.99 (Mar 24) to 51.46, marking an increase of 27.47.
• For Diluted EPS (Rs.), as of Mar 25, the value is 50.79. This value is within the healthy range. It has increased from 23.64 (Mar 24) to 50.79, marking an increase of 27.15.
• For Cash EPS (Rs.), as of Mar 25, the value is 88.79. This value is within the healthy range. It has increased from 57.78 (Mar 24) to 88.79, marking an increase of 31.01.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 558.64. It has increased from 513.34 (Mar 24) to 558.64, marking an increase of 45.30.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 558.64. It has increased from 513.34 (Mar 24) to 558.64, marking an increase of 45.30.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,102.90. It has increased from 985.65 (Mar 24) to 1,102.90, marking an increase of 117.25.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 138.04. This value is within the healthy range. It has increased from 95.71 (Mar 24) to 138.04, marking an increase of 42.33.
• For PBIT / Share (Rs.), as of Mar 25, the value is 100.06. This value is within the healthy range. It has increased from 61.62 (Mar 24) to 100.06, marking an increase of 38.44.
• For PBT / Share (Rs.), as of Mar 25, the value is 62.15. This value is within the healthy range. It has increased from 27.58 (Mar 24) to 62.15, marking an increase of 34.57.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 50.81. This value is within the healthy range. It has increased from 23.69 (Mar 24) to 50.81, marking an increase of 27.12.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 50.81. This value is within the healthy range. It has increased from 23.69 (Mar 24) to 50.81, marking an increase of 27.12.
• For PBDIT Margin (%), as of Mar 25, the value is 12.51. This value is within the healthy range. It has increased from 9.70 (Mar 24) to 12.51, marking an increase of 2.81.
• For PBIT Margin (%), as of Mar 25, the value is 9.07. This value is below the healthy minimum of 10. It has increased from 6.25 (Mar 24) to 9.07, marking an increase of 2.82.
• For PBT Margin (%), as of Mar 25, the value is 5.63. This value is below the healthy minimum of 10. It has increased from 2.79 (Mar 24) to 5.63, marking an increase of 2.84.
• For Net Profit Margin (%), as of Mar 25, the value is 4.60. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 4.60, marking an increase of 2.20.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.60. This value is below the healthy minimum of 8. It has increased from 2.40 (Mar 24) to 4.60, marking an increase of 2.20.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.09. This value is below the healthy minimum of 15. It has increased from 4.61 (Mar 24) to 9.09, marking an increase of 4.48.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.12. This value is below the healthy minimum of 10. It has increased from 6.84 (Mar 24) to 9.12, marking an increase of 2.28.
• For Return On Assets (%), as of Mar 25, the value is 3.23. This value is below the healthy minimum of 5. It has increased from 1.76 (Mar 24) to 3.23, marking an increase of 1.47.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.70. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 0.70, marking an increase of 0.20.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.92. This value is within the healthy range. It has increased from 0.72 (Mar 24) to 0.92, marking an increase of 0.20.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.75. It has decreased from 0.77 (Mar 24) to 0.75, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 1.5. It has increased from 1.21 (Mar 24) to 1.25, marking an increase of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.76.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.42. This value is below the healthy minimum of 4. It has increased from 3.30 (Mar 24) to 3.42, marking an increase of 0.12.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 20.85 (Mar 24) to 0.00, marking a decrease of 20.85.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.55 (Mar 24) to 0.00, marking a decrease of 8.55.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 79.15 (Mar 24) to 0.00, marking a decrease of 79.15.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.45 (Mar 24) to 0.00, marking a decrease of 91.45.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.64. This value is within the healthy range. It has increased from 2.81 (Mar 24) to 3.64, marking an increase of 0.83.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.34. This value is below the healthy minimum of 3. It has increased from 1.70 (Mar 24) to 2.34, marking an increase of 0.64.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,949.34. It has increased from 2,253.43 (Mar 24) to 2,949.34, marking an increase of 695.91.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.02. This value is within the healthy range. It has increased from 0.87 (Mar 24) to 1.02, marking an increase of 0.15.
• For EV / EBITDA (X), as of Mar 25, the value is 8.14. This value is within the healthy range. It has decreased from 8.97 (Mar 24) to 8.14, marking a decrease of 0.83.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.50 (Mar 24) to 0.55, marking an increase of 0.05.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 79.14 (Mar 24) to 0.00, marking a decrease of 79.14.
• For Price / BV (X), as of Mar 25, the value is 1.10. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.10, marking an increase of 0.13.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.50 (Mar 24) to 0.55, marking an increase of 0.05.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness